Evolus, Inc. (LON:0K16)
14.58
+0.43 (3.00%)
At close: Jan 31, 2025
Evolus Market Cap
Evolus has a market cap or net worth of 556.56 million as of April 25, 2025. Its market cap has decreased by -11.06% in one year.
Market Cap
556.56M
Enterprise Value
588.89M
Revenue
212.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.58
Market Cap Chart
Since February 8, 2018, Evolus's market cap has increased from 194.93M to 556.56M, an increase of 185.52%. That is a compound annual growth rate of 15.65%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 161.27B |
GSK plc | 56.28B |
Haleon | 34.06B |
Smith & Nephew | 8.68B |
ConvaTec Group | 5.25B |
Hikma Pharmaceuticals | 4.19B |
HUTCHMED (China) | 1.95B |
Oxford Nanopore Technologies | 1.14B |